![Steven Tuch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven Tuch
Directeur van Onderzoek - Eigen Vermogen bij
Mizuho Securities USA LLC
Profiel
Mr. Steven Tuch is a Managing Director & Co-Head of Healthcare Equity Capital Markets at Mizuho Securities USA LLC.
Mr. Tuch was previously employed as a Chief Financial Officer & Executive Vice President by vTv Therapeutics, Inc. and a Head-Corporate Development by Rallybio Corp.
He received his undergraduate degree from the University of Michigan and an MBA from Stanford Graduate School of Business.
Actieve functies van Steven Tuch
| Bedrijven | Functie | Begin |
|---|---|---|
Mizuho Securities USA LLC
 Mizuho Securities USA LLC Investment Banks/BrokersFinance Provides brokerage services | Directeur van Onderzoek - Eigen Vermogen | 01-03-2025 |
Eerdere bekende functies van Steven Tuch
| Bedrijven | Functie | Einde |
|---|---|---|
| VTV THERAPEUTICS INC. | Financieel Directeur/CFO | 21-03-2025 |
| RALLYBIO CORPORATION | Corporate Officer/Principal | 01-01-2022 |
Opleiding van Steven Tuch
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
18
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Mizuho Securities USA LLC
Mizuho Securities USA LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
vTv Therapeutics, Inc.
 vTv Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company which engages in discovery and development of orally administered small molecule drugs for treating metabolic and inflammatory disorders | Health Technology |
Rallybio Corp.
 Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases | Health Technology |
Kies MarketScreener 
